Immune mechanisms of Concanavalin A model of autoimmune hepatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

1030

HTML

9870

Figures (1-2)

232

Tables (1-2)

234

Sum=11366

Jan 14, 2012 (publication date) through Nov 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 14, 2012; 18(2): 119-125
Published online Jan 14, 2012. doi: 10.3748/wjg.v18.i2.119

Table 2 New drugs developed based on the Concanavalin A model

CpG ODN: CpG-containing oligodeoxynucleotides; ApoA: Apolipoprotein A; Anti-his H1: Antibody against histone H1; NF-κB: Nuclear factor kappa B.

Citation: Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, Guan W, Yuan YS, Gao J. Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol 2012; 18(2): 119-125
URL: https://www.wjgnet.com/1007-9327/full/v18/i2/119.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i2.119